Citadel Advisors’s Orchestra BioMed OBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $337K | Buy |
79,185
+49,010
| +162% | +$209K | ﹤0.01% | 10211 |
|
|
2025
Q4 | $125K | Sell |
30,175
-23,827
| -44% | -$96.1K | ﹤0.01% | 11463 |
|
|
2025
Q3 | $134K | Buy |
54,002
+4,561
| +9% | +$12.6K | ﹤0.01% | 11622 |
|
|
2025
Q2 | $133K | Buy |
49,441
+28,961
| +141% | +$84.5K | ﹤0.01% | 11074 |
|
|
2025
Q1 | $87.7K | Buy |
20,480
+8,201
| +67% | +$40.8K | ﹤0.01% | 11649 |
|
|
2024
Q4 | $49.1K | Sell |
12,279
-7,836
| -39% | -$42.1K | ﹤0.01% | 12408 |
|
|
2024
Q3 | $103K | Buy |
+20,115
| New | +$131K | ﹤0.01% | 11073 |
|
|
2024
Q1 | – | Sell |
-10,112
| Closed | -$92.3K | – | 15287 |
|
|
2023
Q4 | $92.3K | Sell |
10,112
-160,309
| -94% | -$1.09M | ﹤0.01% | 11030 |
|
|
2023
Q3 | $1.49M | Hold |
170,421
| – | – | ﹤0.01% | 5784 |
|
|
2023
Q2 | $1.19M | Hold |
170,421
| – | – | ﹤0.01% | 6097 |
|
|
2023
Q1 | $3.34M | Sell |
170,421
-37
| -0% | -$428 | ﹤0.01% | 4468 |
|
|
2022
Q4 | $1.7M | Sell |
170,458
-1,350
| -0.8% | -$13.4K | ﹤0.01% | 5775 |
|
|
2022
Q3 | $1.7M | Sell |
171,808
-79,160
| -32% | -$785K | ﹤0.01% | 5898 |
|
|
2022
Q2 | $2.5M | Sell |
250,968
-10,626
| -4% | -$106K | ﹤0.01% | 5106 |
|
|
2022
Q1 | $2.59M | Sell |
261,594
-1,687
| -0.6% | -$16.7K | ﹤0.01% | 5506 |
|
|
2021
Q4 | $2.63M | Buy |
263,281
+3,457
| +1% | +$34.1K | ﹤0.01% | 5600 |
|
|
2021
Q3 | $2.57M | Buy |
259,824
+4,385
| +2% | +$43.3K | ﹤0.01% | 5740 |
|
|
2021
Q2 | $2.6M | Sell |
255,439
-3,651
| -1% | -$37.8K | ﹤0.01% | 5933 |
|
|
2021
Q1 | $2.91M | Buy |
259,090
+9,090
| +4% | +$111K | ﹤0.01% | 5519 |
|
|
2020
Q4 | $3.2M | Hold |
250,000
| – | – | ﹤0.01% | 4489 |
|
|
2020
Q3 | $2.75M | Buy |
+250,000
| New | +$2.81M | ﹤0.01% | 4123 |
|
Other funds holding OBIO
RI
PA
VCM
PBM
AAA
